{"nct_id":"NCT03866369","title":"Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose","status":"COMPLETED","status_verified_date":"2019-10","start_date":"2019-01-17","start_date_type":"ACTUAL","primary_completion_date":"2019-08-27","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["IVA"]}